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GPIIb-IIIa administrated within 2 weeks before study, CABGwithin
2 months or PCI within 6 months before study, STEMI undergone
thrombolytic undergone within 48 h, unprotected LMCA >50%
stenosis, sever coronary calciﬁcation, target lesion in SVG, acute
STEMI with a primary PCI strategy and contraindication to antic-
oagulant therapy.
The patients were randomized alternately to intracoronary and
intravenous tiroﬁban. Fifty seven patients were given intracoron-
ary tiroﬁban and taken as study population and ﬁfty eight patients
were given intravenous tiroﬁban and taken as control population.
In the control group, tiroﬁban was given intravenously as a bolus
(10 mg/kg over 3 min) followed by maintenance intravenous infu-
sion at 0.15 mg/kg/min for 36 h. In the study group, tiroﬁban was
administered as an intracoronary bolus injection (10 mg/kg over
3 min) followed by maintenance intravenous infusion at 0.15 mg/
kg/min for 36 h. All patients were evaluated at the end of 14 and 30
day period. Flow in the PCI-targeted coronary arterieswas assessed
by thrombolysis in myocardial infarction (TIMI) ﬂowgrade. Left
ventricular ejection fraction (LVEF) was assessed by standard 2-
dimensional echocardiography at 14 and 30 days after PCI. Major
adverse cardiac events (MACE), such as death, non-fatal myocar-
dial infarction or re-infarction, revascularization of targeted ves-
sels, or worsening left ventricular dysfunction, were also assessed
at 14 days and 30 days following PCI. Major and minor bleeding
complications within 14 days also evaluated.
Results: Comparedwith the control group, the study group showed
better TIMI ﬂow grades and TIMI myocardial perfusion grades
(TMPG) immediately after PCI ( p = 0.016 and 0.026, respectively).
The 14-day composite MACE rate was lower in the study group
(3.5% vs 17.5%, p = 0.030), but was similar between the 2 groups at
30 days following PCI (7.0% vs 1.7%, p = 0.350). The LVEF in the study
group was higher than in the control group 30 days following PCI
(67.4  6.2% vs 60.7  4.6%, p = 0.033). The 14-day bleeding compli-
cation ( p = 0.201) was similar between the 2 groups.
Conclusion: In patients with ACS undergoing primary PCI, intra-
coronary bolus administration of tiroﬁban is superior to intrave-
nous bolus injection for improving coronary ﬂow, myocardial
perfusion and short-term clinical outcome.
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Background: The aim of treatment for acute myocardial infarction
(AMI) is to restore full antegrade blood ﬂow in the infarct-related
artery and minimize ischemic damage to the myocardium. How-
ever, primary PCI is associated with a serious problem known as
the no-reﬂowphenomenon (thrombolysis inmyocardial infarction
(TIMI) ﬂow ≤2), which occurs in 5–25% of cases.
Methods: This is a case control study of all consecutive patients
with AMI admitted at our institution and underwent primary PCI
from August 2014 to February 2015 based on ACC/AHA guidelines.
Results: In the 181 patients who had undergone primary PCI, 47
(25.9%) showed an angiographic no-reﬂow phenomenon.
Multiple stepwise logistic regression analysis identiﬁed that reper-
fusion time >6 h (OR = 13.844, 95%CI 3.214–59.636, p = <0.001), age
>60 years (OR = 8.886, 95%CI 2.145–36.80, p = 0.003), a long target
lesion (OR = 8.637, 95%CI 1.975–37.768, p = 0.004), low initial TIMI
ﬂow (≤1) (OR = 20.861, 95%CI 1.739–250.290, p = 0.017) were the
independent predictors of the no-ﬂow phenomenon in our study.
Conclusions: In conclusion, the pathogenesis of no-reﬂow phe-
nomenon is complex and multifactorial. In the light of our recent
study, patients who are likely to develop the no-reﬂow phenom-
enon after primary PCI can be predicted by simple clinical and
angiographic features.
It is important to avoid or minimize trauma to the vessel, avoid
repetitive balloon dilatations and use the shortest stent if possible.
Because most patients with AMI have a combination of these
factors, combined treatment strategies should be preferred.
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Background: Acute myocardial infarction below 45 years of age
constitutes a speciﬁc subset of population having different risk
factors and clinical features and prognosis as compared to older
patients. The protection offered by young age has been slowly
taken away by the increased prevalence of risk factors for CHD in
adolescents such as smoking, obesity, and lack of physical activity.
Objective: The purpose of this study is to describe the risk factors,
clinical features, angiographic patterns and outcomes in AMI in
young patients (<45 years) and to compare the samewith the older
subjects (>45 years) and to study the various complications in 7
days follow up.
Material andmethods: The present studywas carried out at the LPS
institute of cardiology Kanpur. Total 150 cases of acute myocardial
infarction admitted in ICCU during 1st January 2014 to 1st January
2015 were enrolled and were categorized in two groups: (a) Group I
– age <45 years, b) Group II age ≥45 years. Fasting blood glucose,
fasting lipid proﬁle, serial ECGs and the cardiac enzymes (troponin
T and I) were evaluated. The risk factors which were studied were
hypertension, diabetes mellitus, smoking habits, overweight,
waist to hip ratio, hyperlipidemia and family history.
Results: Mean age of the cases was 38  7 and 68.2  5 in group I
and II respectively. The male and female ratio was 3:1 in group I
and 1.5:1 in group II. Atypical chest pain, sweating, dyspnea and
giddiness were less frequently in the younger group with AMI than
group II. Younger subjects arriving within 6 h of chest pain was
signiﬁcantly more as in no compared to older subjects (49/65 i.e.
75% vs 38/85 i.e. 45%, p = <0.05). Tobacco consumption was the
most common risk factor in group I (71% vs 25% in group II).
Anterior wall MI, (including lateral MI) was the most common
presentation present in 57.64% of the patients in group I vs 45%
in group II. The incidence of major complications like congestive
cardiac failure, arrhythmias, cardiogenic shock were signiﬁcantly
less in the younger group (50%, 20%, 5%) as compared to (75%, 55%,
15%) respectively in older group. Mortality was signiﬁcantly lower
in group (I) than (group II) 5% vs 20%. Angiography results showed
SVD in 48% patients in group I vs 25% in group II. TVD was present
in only 3% of the patients in group I vs 27% in group II. LMCA was
involved in 3% in group I vs 12% in group II. Normal or nonsigni-
ﬁcant coronaries were present in 18% in group I vs 2% in group II.
From these results we conclude that Myocardial infarction before
age 45 is a disease of men. Young patients tend to have less
extensive coronary artery lesions. Very low prevalence of Triple-
vessel disease is present. Young patients have more favourable in
hospital prognosis than their older counterparts. A sizeable pro-
portion of patients will have normal coronary arteries. Health
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) s 1 7 – s 4 8 S39
intervention measures like quitting smoking would play a key role
in preventing MI in young adults.
Intravascular ultrasound assessment
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Background: Our present knowledge and guidelines direct us only
to intervene on infarct related artery in STEMI patients during
Primary PCI. But vulnerable plaques do coexist in other coronaries
and can lead to fatal cardiac events in future.We took up this study
to know the actual prevalence of plaques, including their char-
acteristics & compositions in the non-infarct arteries.
Materials and methods: Forty patients undergoing PCI following
STEMI, underwent virtual histology-intravascular ultrasound (VH-
IVUS) study in proximal 10 mmsegments of the non-infarct related
arteries (non-IRA), excluding non-dominant RCA. Prevalence of
plaques and plaque composition was assessed and statistically
analyzed.
Results: A total of 37 plaques in non-infarct arteries were detected
in 34 patients among the study population. Three patients had
plaques in both the non-IRA vessels. Out of these 18 plaques were
present in LAD among which 10 were vulnerable plaques. Twelve
plaques were found in RCA comprising of 5 vulnerable plaques.
Only 7 plaqueswere found in non-infarcted LCX, out ofwhich there
were 2 vulnerable plaques. Among the IVUS parameters mean
plaque volume was 57.8 mm3. Major contribution in plaque
volume was from ﬁbrous tissue, which constituted 58.6%. Rest
was 19.7% ﬁbro-fatty tissue and necrotic core was quite prevalent
with a mean proportion of 12.9%. Proportion of calciﬁc plaque was
8.7%.
Conclusion: Patients presenting with STEMI actually have variable
number of stable and vulnerable plaques in non-infarct arteries.
LAD is most common artery to harbor non-IRA plaques. Cardio-
vascular risk factors are more prevalent in patients with non-IRA
plaques, although not statistically signiﬁcant.
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Background: Coronary artery disease particularly acute myocar-
dial infarction in young generations is fast growing due to
change in demographic proﬁle, economic status and life style
inversion. They are an important group to examine with regard
to risk factor modiﬁcation and secondary prevention. AMI in
young patients has different characteristics from that in older in
many ways, as risk factors, clinical proﬁle, presentation pat-
terns, complications, biochemical parameters, and angiography
proﬁle.
Materials and methods: 25 young patients aged below 40 years,
presenting with acute myocardial infarction, admitted in cardiol-
ogyward or ICCU inMedical college and hospital, Kolkata in 2014 (1
year) were made part of this study.
Results: Average age of the patients was 38 years. 80% were male.
Average time of presentation was 27 h with only 20% of the
patients coming within 12 h and 40% getting thrombolysis. Aver-
age BMI of the patients was 23 kg/m2. 78% patients were smokers,
65% were hypertensive, 30% were diabetic, 35% were dyslipidemic
and 32% having all these 4 risk factors. Average presenting blood
pressure was 145/90 and pulse 102/min. 45% patients had anterior
wall myocardial infarction, 30% inferior wall MI and 25 having
NSTEMI. Average ejection fractionwas 42with 32%patients having
EF less than 40. In coronary angiography 2 out of 25 patients (8%)
had almost normal coronaries, 52% had signiﬁcant LAD lesion, 28%
had signiﬁcant RCA stenosis and 20% had LCX lesion. 8% patients
had left main coronary artery lesion, 8% had 2 vessel disease and
4% had 3 vessel disease.
Conclusion: This study shows detailed characteristics of young
patients presenting with AMI, including risk factors, clinical pre-
sentations, biochemical parameters, angiographic proﬁle and
helps to understand the whole spectrum, which is different from
their older-age counter-part and reiterates the need of establishing
thorough system for early recognition, prevention and awareness
of CAD among young generations in India.
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Background: Cardiovascular diseases (CVD) are the leading cause
of death in theWorld (31% of all deaths) andMongolia as well. CVD
has been the leading cause of death in Mongolia for the last 20
years and consists one of 3 death cases. In its turn 59.6% of CVD
mortality caused by ischemic heart diseases.
When the coronary atherosclerotic plaque becomes vulnerable, a
thrombus develops on that ruptured plaque and then occludes the
coronary artery, which causes acute blood deﬁciency in the down-
stream myocardium. Some studies indicate that matrix metallo-
proteinase-9 (MMP-9) plays a key role on pathogenesis of plaque
rupture.
Objectives: To study the involvement of serum MMP-9 enzyme in
the pathogenesis during the rupture of the coronary atherosclero-
sis plaque.
Methods: The study was conducted using case–control design. The
main inclusion criteria of the case group is that the patient should
have a ruptured coronary atherosclerotic plaque, conﬁrmed by
clinical sign, ECG, troponin I, angiography. The total number of
patients is 80, half of them belongs to the case group. MMP-9 was
determined in serum by ELISA. We used CIIS (cardiac infarction
injury score) by ECG and Gensini score system (coronary angio-
graphic scoring system) for assessing the severity of coronary heart
disease.
Results: The average level of MMP-9 in case and control groups is
0.396  0.155 ng/ml, 0.223  0.087 ng/ml respectively with
p < 0.001 signiﬁcance which shows MMP-9 (OR = 0.001, p < 0.001)
may play a role in the pathogenesis of plaque rupture. MMP-9 is
correlatedwith Gensini score and CIIS score, respectively (r = 0.552,
p < 0.01; r = 0.340, p < 0.01) which shows MMP-9 is being elevated
with the increase of the severity of coronary heart disease and the
cardiac infarction injury.
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